Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus of $361.96 million and the management guidance of $360 million to $365 million. Revenue increased by 1.6% on an organic basis, excluding Boston. Integra Lifesciences reported an adjusted EPS of $0.55, which is in line with the consensus and lower than $0.74 a year ago. The management had forecasted
By Masakazu Takeda, Kohei Matsu and Angus Lee
"My family and I have been fans of Talenti for years," said the Oscar-nominated actor, who stars in two cheeky ads